Sign up
Healthed-White-on-Blue

Lifestyle

fascia
Alison Slater
Podcasts iconPodcasts

Fascia: The hidden network changing how we understand pain

Physiotherapist Alison Slater reveals why fascia, a dynamic, innervated system is key to understanding movement, chronic pain, and patient care, challenging traditional musculoskeletal paradigms and offering practical insights for clinicians.

Expert/s: Alison Slater
1708015534
Samuel Cornell
Clinical Articles iconClinical Articles

More women are using steroids, and many don’t know the risks

What's behind the rise, and why harm minimisation needs to target women too

Expert/s: Samuel Cornell, Timothy Piatkowski
shutterstock_2550410531
A/Prof Joyce Siette
Clinical Articles iconClinical Articles

Exercising in mid and later life can reduce dementia risk – new study

For years, scientists have known that moving our bodies can sharpen our minds. Physical activity boosts blood flow to the brain, enhances neuroplasticity and reduces chronic inflammation. These processes are believed to protect against cognitive decline, including dementia.

Expert/s: A/Prof Joyce Siette
shutterstock_2018677748
A/Prof Gilles E. Gignac
Clinical Articles iconClinical Articles

Worried about turning 60? Science says that’s when many of us actually peak

As your youth fades further into the past, you may start to fear growing older.

Expert/s: A/Prof Gilles E. Gignac
Overweight,Woman,Having,Consultation,At,Doctor's,Office
A/Prof Samantha Hocking
Clinical Articles iconClinical Articles

Tirzepatide vs semaglutide: A head-to-head comparison for management of obesity

The SURMOUNT-5 trial has provided definitive evidence that tirzepatide is superior to semaglutide for obesity treatment, achieving an additional 6.5% body weight reduction and nearly doubling the proportion of patients who lose 25% or more of their body weight.

Expert/s: A/Prof Samantha Hocking
Asian,Man,Sleeping,Calmly,With,Cpap,Nasal,Mask,In,Bed,
Prof Brendon Yee
Clinical Articles iconClinical Articles

GLP-1 and GLP-1/GIP RAs for obstructive sleep apnoea – What is their role?

With obesity demonstrating mortality rates comparable to cigarette smoking and obstructive sleep apnoea (OSA) potentially affecting up to one billion people worldwide, the intersection of these conditions demands innovative therapeutic approaches. Recent advances in incretin-based therapies, particularly the GLP-1/GIP receptor agonist tirzepatide (Mounjaro), are revolutionising treatment for patients with concurrent obesity and OSA, offering clinically significant improvements that may challenge traditional CPAP-centric management strategies.

Expert/s: Prof Brendon Yee
shutterstock_643134019 (1)
Lynnette Hoffman
Clinical Articles iconClinical Articles

Simple muscle-building strategies for older patients

‘Strength snacking,’ one-minute screening and other practical ways to support mobility and independence

Expert/s: Lynnette Hoffman
Young,Man,Suffering,From,Knee,Pain,At,Home,,Close,Up.
Dr Samuel Whittle
Clinical Articles iconClinical Articles

Stem cell treatments for knee osteoarthritis

People are getting costly stem cell injections for knee osteoarthritis. But we don’t know if they work.

Expert/s: Dr Samuel Whittle
Nature prescriptions
A/Prof Vicki Kotsirilos AM
Podcasts iconPodcasts

Nature prescriptions: What are the health benefits

In today’s podcast, A/Prof Vicki Kotsirilos AM explores how spending time in nature could boost mental health, lower blood pressure, improve sleep, and support child development.

Expert/s: A/Prof Vicki Kotsirilos AM
Negative,Customer,Review,Concept.,A,Person,Use,Smartphone,To,Give
Sophia Auld
Clinical Articles iconClinical Articles

51% of clinics have had unfair online reviews – survey

One in four GPs say they’ve personally had one - here’s what to do

Expert/s: Sophia Auld
shutterstock_1195014727
Dr Kuljit Singh
Podcasts iconPodcasts

The role of social prescribing

Dr Kuljit Singh discusses conversation starters of social prescribing, community belonging and engagement by linking individuals to local resources, and the positive impact of social prescribing on health outcomes.

Expert/s: Dr Kuljit Singh
shutterstock_1955541622(1)
Prof Lauren Ball
Clinical Articles iconClinical Articles

Scurvy is largely a historical disease but there are signs it’s making a comeback

Doctors in developed countries have recently reported treating cases of scurvy - as well as Australian doctors.

Expert/s: Prof Lauren Ball

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform